Healthium commenced its operations at the Sri City facility in the calendar year 2012
Healthium Medtech has received US FDA (US Food and Drug Administration) registration for its manufacturing facility in Sri City, Andhra Pradesh.
Based on the focus placed on creating high-quality precision-based medical devices, Healthium’s manufacturing facilities are subjected to rigorous quality control checks and periodic inspections from various regulatory agencies across the world. The accreditation of our manufacturing facilities reiterates our focus on patient safety and is an essential requirement for our products to be used in the treatment of patients globally. As of March 31, 2021, one in five surgeries conducted globally, uses a Healthium product.
Healthium commenced its operations at the Sri City facility in the calendar year 2012. The facility manufactures sutures, meshes with a production capacity of 1.20 million, as per the fiscal of 2021, and is located in a special economic zone (SEZ).
Anish Bafna, CEO and MD, Healthium Medtech said, “We are delighted to receive the US FDA registration for our Sri City facility in Andhra Pradesh, our 4th facility to receive it. This is testimony to our commitment to operational excellence and to our focus on delivering high quality, safe, value-driven products aligned with our vision “Access to precision medtech for every patient, globally.”